After a well-documented recovery following substantial population declines throughout most of North America, the Peregrine Falcon (Falco peregrinus) was delisted under provisions of the Endangered Species Act in 1999. Post-delisting monitoring for the Peregrine Falcon stipulated surveys of breeding locations and did not specifically emphasize other metrics of population dynamics such as survival. We used banding data from Peregrine Falcons captured on the Washington coast during 1212 vehicle surveys between 1995 and 2018 to assess apparent survival and resighting frequencies. Our mark-recapture data set included 226 Peregrine Falcons: 148 females and 78 males. Fourteen Peregrine Falcons were recovered dead and another eight were found injured or uninjured and unable to fly due to illness or substantially soiled feathers. We had 744 resightings, 67.1% (n = 499) by our research group during surveys (Group A) and 32.9% (n = 245) by others (Group B). We found a dramatic increase in Group B contributions beginning in 2008 due to the emergence of digital camera use in wildlife photography and increased public awareness of our project. Data from 1995 to 2018 supported the estimation of apparent survival for three age classes of Peregrine Falcons: 0.424 (SE = 0.057) for hatch-year (<1 yr old); 0.663 (SE = 0.066) for second-year (1–2 yr old), and 0.738 (SE = 0.030) for after-second-year (>2 yr old). Our long-term mark-resighting analyses of overwintering and migratory Peregrine Falcons along the Washington coast provide evidence of a reasonably high level of apparent survival that suggests good population performance.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.
Vol. 54 • No. 3